CLINICAL_TRIALS
trial_result
· 2026-04-17
Clinical Trial Update: A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants [Phase 1]
Summary
This document reports a completed Phase 1 clinical trial of JNJ-75229414 for metastatic castration-resistant prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Phase 1 | Status: COMPLETED